Terms: = Leukemia AND MAF, MGC71685, 4094, ENSG00000178573 AND Treatment
15 results:
1. Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studies.
Farre L; Sanz G; Ruiz-Xivillé N; Castro de Moura M; Martin-Tejera JF; Gonçalves-Ribeiro S; Martinez-Iniesta M; Calaf M; Luis Mosquera J; Martín-Subero JI; Granada I; Esteller M; Domingo-Domenech E; Climent F; Villanueva A; Sureda A
Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 33988237
[TBL] [Abstract] [Full Text] [Related]
2. Diverse roles of the E2/E3 hybrid enzyme UBE2O in the regulation of protein ubiquitination, cellular functions, and disease onset.
Ullah K; Zubia E; Narayan M; Yang J; Xu G
FEBS J; 2019 Jun; 286(11):2018-2034. PubMed ID: 30468556
[TBL] [Abstract] [Full Text] [Related]
3. Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia.
Gutierrez-Camino Á; Umerez M; Martin-Guerrero I; García de Andoin N; Santos B; Sastre A; Echebarria-Barona A; Astigarraga I; Navajas A; Garcia-Orad A
Pharmacogenomics J; 2018 Dec; 18(6):704-712. PubMed ID: 29282364
[TBL] [Abstract] [Full Text] [Related]
4. Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.
Nair JR; Caserta J; Belko K; Howell T; Fetterly G; Baldino C; Lee KP
Leukemia; 2017 Aug; 31(8):1715-1726. PubMed ID: 28008178
[TBL] [Abstract] [Full Text] [Related]
5. [Molecular Mechanism and Malignant Clonal Evolution of Multiple Myeloma].
Ding F; Zhu P; Wu XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1513-6. PubMed ID: 26524068
[TBL] [Abstract] [Full Text] [Related]
6. HTLV-1 basic leucine-zipper factor, HBZ, interacts with mafB and suppresses transcription through a maf recognition element.
Ohshima T; Mukai R; Nakahara N; Matsumoto J; Isono O; Kobayashi Y; Takahashi S; Shimotohno K
J Cell Biochem; 2010 Sep; 111(1):187-94. PubMed ID: 20506502
[TBL] [Abstract] [Full Text] [Related]
7. Expression of heme oxygenase-1 in human leukemic cells and its regulation by transcriptional repressor Bach1.
Miyazaki T; Kirino Y; Takeno M; Samukawa S; Hama M; Tanaka M; Yamaji S; Ueda A; Tomita N; Fujita H; Ishigatsubo Y
Cancer Sci; 2010 Jun; 101(6):1409-16. PubMed ID: 20345481
[TBL] [Abstract] [Full Text] [Related]
8. Hemin reduces cellular sensitivity to imatinib and anthracyclins via Nrf2.
Nagai T; Kikuchi S; Ohmine K; Miyoshi T; Nakamura M; Kondo T; Furuyama K; Komatsu N; Ozawa K
J Cell Biochem; 2008 May; 104(2):680-91. PubMed ID: 18172853
[TBL] [Abstract] [Full Text] [Related]
9. Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization: evidence of distinct clonal origin.
Chang H; Wechalekar A; Li L; Reece D
Cancer Genet Cytogenet; 2004 Jan; 148(1):44-8. PubMed ID: 14697640
[TBL] [Abstract] [Full Text] [Related]
10. Heme positively regulates the expression of beta-globin at the locus control region via the transcriptional factor Bach1 in erythroid cells.
Tahara T; Sun J; Nakanishi K; Yamamoto M; Mori H; Saito T; Fujita H; Igarashi K; Taketani S
J Biol Chem; 2004 Feb; 279(7):5480-7. PubMed ID: 14660636
[TBL] [Abstract] [Full Text] [Related]
11. B-cell-specific transcription factor BACH2 modifies the cytotoxic effects of anticancer drugs.
Kamio T; Toki T; Kanezaki R; Sasaki S; Tandai S; Terui K; Ikebe D; Igarashi K; Ito E
Blood; 2003 Nov; 102(9):3317-22. PubMed ID: 12829606
[TBL] [Abstract] [Full Text] [Related]
12. A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells.
Homolya L; Holló M; Müller M; Mechetner EB; Sarkadi B
Br J Cancer; 1996 Apr; 73(7):849-55. PubMed ID: 8611394
[TBL] [Abstract] [Full Text] [Related]
13. Human macrophage-activating factors for cytotoxicity. I. Establishment of a human T-cell hybridoma that produces macrophage-activating factors for cytotoxicity.
Higuchi M; Sugimoto M; Kobayashi Y; Osawa T
Microbiol Immunol; 1987; 31(5):469-79. PubMed ID: 3116371
[TBL] [Abstract] [Full Text] [Related]
14. Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
Kleinerman ES; Zicht R; Sarin PS; Gallo RC; Fidler IJ
Cancer Res; 1984 Oct; 44(10):4470-5. PubMed ID: 6088039
[TBL] [Abstract] [Full Text] [Related]
15. Triple drug chemotherapy for advanced ovarian carcinoma: comparative study of two regimens.
Aroney RS; Levi JA; Dalley DN
Med J Aust; 1981 Jun; 1(12):633-5. PubMed ID: 7019638
[TBL] [Abstract] [Full Text] [Related]
